Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide 1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study
-
Published:2024-04
Issue:
Volume:
Page:
-
ISSN:0016-5107
-
Container-title:Gastrointestinal Endoscopy
-
language:en
-
Short-container-title:Gastrointestinal Endoscopy
Author:
Busch Celine B.E.,
Meiring Suzanne,
van Baar Annieke C.G.ORCID,
Holleman Frits,
Nieuwdorp Max,
Bergman Jacques J.G.H.M.
Reference34 articles.
1. World Health Organization. Diabetes. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed March 23, 2023.
2. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future;Kahn;Lancet,2014
3. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetologia,2015
4. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer;Holden;Diabetes Obes Metab,2015
5. Insulin-associated weight gain in diabetes—causes, effects and coping strategies;Russell-Jones;Diabetes Obes Metab,2007